Baron Global Durable Advantage ETF declined 7.3% (NAV) during the first quarter, compared to the 3.2% decline for the MSCI ...
The global dual chamber devices market presents growth opportunities driven by the rising demand for patient-friendly, accurate drug delivery systems, particularly in biologics. Advancements in ...